Wu CW - Search Results

1

Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.

Hong SY, Kao YR, Lee TC, Wu CW. Hong SY, et al. Among authors: wu cw. Cancer Res. 2018 Sep 1;78(17):4984-4996. doi: 10.1158/0008-5472.CAN-17-3858. Epub 2018 Jun 26. Cancer Res. 2018. PMID: 29945960

2

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW. Chou YT, et al. Among authors: wu cw. Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26. Cancer Res. 2010. PMID: 20978205

3

Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma.

Lin EH, Kao YR, Lin CA, Kuo TY, Yang SP, Hsu CF, Chou TY, Ho CC, Wu CW. Lin EH, et al. Among authors: wu cw. Oncotarget. 2016 Apr 26;7(17):24179-93. doi: 10.18632/oncotarget.8253. Oncotarget. 2016. PMID: 27015549 Free PMC article.

4

Epigenetic Switch between SOX2 and SOX9 Regulates Cancer Cell Plasticity.

Lin SC, Chou YT, Jiang SS, Chang JL, Chung CH, Kao YR, Chang IS, Wu CW. Lin SC, et al. Among authors: wu cw. Cancer Res. 2016 Dec 1;76(23):7036-7048. doi: 10.1158/0008-5472.CAN-15-3178. Epub 2016 Oct 7. Cancer Res. 2016. PMID: 27758880

5

Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition.

Wang CY, Lee MH, Kao YR, Hsiao SH, Hong SY, Wu CW. Wang CY, et al. Among authors: wu cw. Biochim Biophys Acta Mol Cell Res. 2021 May;1868(6):119016. doi: 10.1016/j.bbamcr.2021.119016. Epub 2021 Mar 17. Biochim Biophys Acta Mol Cell Res. 2021. PMID: 33744274 Free article.

6

Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.

Hong SY, Lu YC, Hsiao SH, Kao YR, Lee MH, Lin YP, Wang CY, Wu CW. Hong SY, et al. Among authors: wu cw. Oncogene. 2022 Mar;41(13):1907-1917. doi: 10.1038/s41388-022-02180-6. Epub 2022 Feb 12. Oncogene. 2022. PMID: 35149839

7

Expression of axl in lung adenocarcinoma and correlation with tumor progression.

Shieh YS, Lai CY, Kao YR, Shiah SG, Chu YW, Lee HS, Wu CW. Shieh YS, et al. Among authors: wu cw. Neoplasia. 2005 Dec;7(12):1058-64. doi: 10.1593/neo.05640. Neoplasia. 2005. PMID: 16354588 Free PMC article.

8

Brain metastases in patients with non-small cell lung cancer: the role of mutated-EGFRs with an exon 19 deletion or L858R point mutation in cancer cell dissemination.

Hsiao SH, Chou YT, Lin SE, Hsu RC, Chung CL, Kao YR, Liu HE, Wu CW. Hsiao SH, et al. Among authors: wu cw. Oncotarget. 2017 Jun 16;8(32):53405-53418. doi: 10.18632/oncotarget.18509. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881820 Free PMC article.

9

YAP1 is essential for tumor growth and is a potential therapeutic target for EGFR-dependent lung adenocarcinomas.

Lee TF, Tseng YC, Chang WC, Chen YC, Kao YR, Chou TY, Ho CC, Wu CW. Lee TF, et al. Among authors: wu cw. Oncotarget. 2017 Jul 27;8(52):89539-89551. doi: 10.18632/oncotarget.19647. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163769 Free PMC article.

10

Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram.

Shian SG, Kao YR, Wu FY, Wu CW. Shian SG, et al. Among authors: wu cw, wu fy. Mol Pharmacol. 2003 Nov;64(5):1076-84. doi: 10.1124/mol.64.5.1076. Mol Pharmacol. 2003. PMID: 14573756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,474 results

Search Page

Filters